Persistent Iron Deficiency and Dysregulated Hepcidin Levels After Durable Left Ventricular Assist Device Therapy
ASAIO J
.
2023 Apr 1;69(4):e152-e154.
doi: 10.1097/MAT.0000000000001811.
Epub 2022 Sep 9.
Authors
Van-Khue Ton
1
,
Kamila Drezek
2
,
Sophie Boerboom
1
,
Katrina F Ostrom
1
,
Claire Birchenough
1
,
Janice Camuso
2
,
Tara Logan
2
,
Katherine Milley
2
,
Alexandra Anthony
2
,
Sunu S Thomas
1
,
Erin Coglianese
1
,
David D D'Alessandro
2
,
Rajeev Malhotra
1
,
Gregory D Lewis
1
Affiliations
1
From the Division of Cardiology, Massachusetts General Hospital, Boston, Massachusetts and.
2
Division of Cardiac Surgery, Massachusetts General Hospital, Boston, Massachusetts.
PMID:
36084293
DOI:
10.1097/MAT.0000000000001811
No abstract available
MeSH terms
Heart Failure* / surgery
Heart-Assist Devices*
Hepcidins
Humans
Iron Deficiencies*
Substances
Hepcidins